-
Alternative name
Coagulation factor X ELISA KIT; Stuart factor ELISA KIT; Stuart-Prower factorF10 ELISA KIT;
-
Catalog
E009843
-
species
Human
-
GeneFX
-
SpecificityThis assay has high sensitivity and excellent specificity for detection of FX. No significant cross-reactivity or interference between FX and analogues was observed. NOTE: Limited by current skills and knowledge, it is impossible for us to complete the cross-reactivity detection between FX and all the analogues, therefore, cross reaction may still exist in some cases.
-
SamplesSerum, Plasma , tissue homogenates,Cell culture supernates,Other biological fluids.
-
Sensitivity1.0 pg/mL.
-
Intended UseHuman FX ELISA Kit allows for the in vitro quantitative determination of FX , concentrations in serum, Plasma , tissue homogenates and Cell culture supernates and Other biological fluids.
-
StorageFor 5-7days:Store the whole kit at 4℃
For a Long time :Store the Substrate at 4℃, other reagent should store at -20℃.
-
Product Categories/FamilyHuman ELISA Kit
-
Product Description
specificalFor samples: Serum, plasma, cell culture supernatants, body fluid and tissue homogenate
INTENDED USE This FX ELISA kit is a 1.5 hour solid-phase ELISA designed for the quantitative determination of Human FX. This ELISA kit for research use only, not for therapeutic or diagnostic applications!
PRINCIPLE OF THE ASSAY FX ELISA kit applies the competitive enzyme immunoassay technique utilizing a monoclonal anti-FX antibody and an FX-HRP conjugate. The assay sample and buffer are incubated together with FX-HRP conjugate in pre-coated plate for one hour. After the incubation period, the wells are decanted and washed five times. The wells are then incubated with a substrate for HRP enzyme. The product of the enzyme-substrate reaction forms a blue colored complex. Finally, a stop solution is added to stop the reaction, which will then turn the solution yellow. The intensity of color is measured spectrophotometrically at 450nm in a microplate reader. The intensity of the color is inversely proportional to the FX concentration since FX from samples and FX-HRP conjugate compete for the anti-FX antibody binding site. Since the number of sites is limited, as more sites are occupied by FX from the sample, fewer siity of the color (O.D.) to the concentration of standards. The FX concentration tes are left to bind FX-HRP conjugate. A standard curve is plotted relating the intensin each sample is interpolated from this standard curve.
-